The regulatory mechanisms of cerium oxide nanoparticles in oxidative stress and emerging applications in refractory wound care

• Published in: Frontiers in pharmacology 2024-08, Vol.15, p.1439960
• Main Authors: Yi, Lijun, Yu, Lijian, Chen, Shouying, Huang, Delong, Yang, Cheng, Deng, Hairui, Hu, Yiheng, Wang, Hui, Wen, Zhongjian, Wang, Yiren, Tu, Yu
• Format: Article
• Language: English
• Subjects: biocompatibility; cerium oxide nanoparticles; oxidative stress; refractory wound; toxicity; wound care
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2024.1439960

Cerium oxide nanoparticles (CeNPs) have emerged as a potent therapeutic agent in the realm of wound healing, attributing their efficacy predominantly to their exceptional antioxidant properties. Mimicking the activity of endogenous antioxidant enzymes, CeNPs alleviate oxidative stress and curtail the generation of inflammatory mediators, thus expediting the wound healing process. Their application spans various disease models, showcasing therapeutic potential in treating inflammatory responses and infections, particularly in oxidative stress-induced chronic wounds such as diabetic ulcers, radiation-induced skin injuries, and psoriasis. Despite the promising advancements in laboratory studies, the clinical translation of CeNPs is challenged by several factors, including biocompatibility, toxicity, effective drug delivery, and the development of multifunctional compounds. Addressing these challenges necessitates advancements in CeNP synthesis and functionalization, novel nano delivery systems, and comprehensive bio effectiveness and safety evaluations. This paper reviews the progress of CeNPs in wound healing, highlighting their mechanisms, applications, challenges, and future perspectives in clinical therapeutics.